{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:09:09Z","timestamp":1793664549657,"version":"4.5.1"},"reference-count":163,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Interleukin-17 family (IL-17s) comprises six structurally related members (IL-17A to IL-17F); sequence homology is highest between IL-17A and IL-17F, displaying certain overlapping functions. In general, IL-17A and IL-17F play important roles in chronic inflammation and autoimmunity, controlling bacterial and fungal infections, and signaling mainly through activation of the nuclear factor-kappa B (NF-\u03baB) pathway. The role of IL-17A and IL-17F has been established in chronic immune-mediated inflammatory diseases (IMIDs), such as psoriasis (PsO), psoriatic arthritis (PsA), axial spondylarthritis (axSpA), hidradenitis suppurativa (HS), inflammatory bowel disease (IBD), multiple sclerosis (MS), and asthma. CD4\n                    <jats:sup>+<\/jats:sup>\n                    helper T cells (Th17) activated by IL-23 are well-studied sources of IL-17A and IL-17F. However, other cellular subtypes can also produce IL-17A and IL-17F, including gamma delta (\u03b3\u03b4) T cells, alpha beta (\u03b1\u03b2) T cells, type 3 innate lymphoid cells (ILC3), natural killer T cells (NKT), or mucosal associated invariant T cells (MAIT). Interestingly, the production of IL-17A and IL-17F by innate and innate-like lymphocytes can take place in an IL-23 independent manner in addition to IL-23 classical pathway. This would explain the limitations of the inhibition of IL-23 in the treatment of patients with certain rheumatic immune-mediated conditions such as axSpA. Despite their coincident functions, IL-17A and IL-17F contribute independently to chronic tissue inflammation having somehow non-redundant roles. Although IL-17A has been more widely studied, both IL-17A and IL-17F are overexpressed in PsO, PsA, axSpA and HS. Therefore, dual inhibition of IL-17A and IL-17F could provide better outcomes than IL-23 or IL-17A blockade.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2023.1191782","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T13:39:17Z","timestamp":1691156357000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":90,"title":["The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases"],"prefix":"10.3389","volume":"14","author":[{"given":"Victoria","family":"Navarro-Comp\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Llamas-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fern\u00e1ndez-Carballido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Almod\u00f3var","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gal\u00edndez-Aguirregoikoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Zarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Joven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Gratac\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Juanola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Arias-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Sanz Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Queiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan D.","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028522","article-title":"Interleukin 17 family cytokines: signaling mechanisms, biological activities, and therapeutic implications","volume":"10","author":"Monin","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2012.02.008","article-title":"Regulation of epithelial immunity by IL-17 family cytokines","volume":"33","author":"Pappu","year":"2012","journal-title":"Trends Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-051914-021944","article-title":"Therapeutic targeting of IL-17 and IL-23 cytokines in immune-mediated diseases","volume":"67","author":"Fragoulis","year":"2016","journal-title":"Annu Rev Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102429","article-title":"Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies","volume":"19","author":"Ruiz de Morales","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0084-8","article-title":"IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting","volume":"16","author":"Moschen","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637829","article-title":"Role of the IL-23\/IL-17 Pathway in Rheumatic Diseases: An Overview","volume":"12","author":"Schinocca","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594735","article-title":"The IL-23\/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01682","article-title":"The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond","volume":"9","author":"Brembilla","year":"2018","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000805","article-title":"Out of the shadow of interleukin-17A: the role of interleukin-17F and other interleukin-17 family cytokines in spondyloarthritis","volume":"33","author":"Yeremenko","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213328","article-title":"Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study","volume":"77","author":"Baeten","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31946-9","article-title":"Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial","volume":"392","author":"van der Heijde","year":"2018","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30265-8","article-title":"Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis","volume":"71","author":"Deodhar","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s13555-023-00913-3","article-title":"Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial","volume":"13","author":"Kimball","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad010","article-title":"Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study","volume":"188","author":"Dudink","year":"2023","journal-title":"Br J Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01550","article-title":"The Initiation, but Not the Persistence, of Experimental Spondyloarthritis Is Dependent on Interleukin-23 Signaling","volume":"9","author":"van Tok","year":"2018","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30233-4","article-title":"Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study","volume":"3","author":"Feagan","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.298","article-title":"A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease","volume":"111","author":"Targan","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0134-y","article-title":"Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing Treg cells through modification of the intestinal microbiota","volume":"19","author":"Tang","year":"2018","journal-title":"Nat Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155715","article-title":"Divergent functions of IL-17-family cytokines in DSS colitis: Insights from a naturally-occurring human mutation in IL-17F","volume":"148","author":"Zhou","year":"2021","journal-title":"Cytokine."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0141-z","article-title":"Get the IL-17F outta here","volume":"19","author":"Hall","year":"2018","journal-title":"Nat Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.08.019","article-title":"Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation","volume":"43","author":"Maxwell","year":"2015","journal-title":"Immunity."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585134","article-title":"Interleukin (IL)-12 and IL-18 Synergize to Promote MAIT Cell IL-17A and IL-17F Production Independently of IL-23 Signaling","volume":"11","author":"Cole","year":"2020","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215210","article-title":"Evidence that tissue resident human enthesis gammadeltaT-cells can produce IL-17A independently of IL-23R transcript expression","volume":"78","author":"Cuthbert","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20827","article-title":"Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double-blind multicentre study","volume":"186","author":"Oliver","year":"2022","journal-title":"Br J Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212127","article-title":"Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation","volume":"77","author":"Glatt","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001306","article-title":"Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells","volume":"6","author":"Shah","year":"2020","journal-title":"RMD Open"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/2040622321103784634","article-title":"Dual inhibition of IL-17A and IL-17F in psoriatic disease","volume":"12","author":"Iznardo","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141557","article-title":"IL-17 family cytokines and the expanding diversity of effector T cell lineages","volume":"25","author":"Weaver","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200848","article-title":"Finer linkage mapping of a primary hip osteoarthritis susceptibility locus on chromosome 6","volume":"10","author":"Loughlin","year":"2002","journal-title":"Eur J Hum Genet"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.19.5332","article-title":"IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding","volume":"20","author":"Hymowitz","year":"2001","journal-title":"EMBO J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-981-13-9367-9_5","article-title":"Structural Insights into the Interleukin-17 Family Cytokines and Their Receptors","volume":"1172","author":"Liu","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.4.2799","article-title":"The human IL-17F\/IL-17A heterodimeric cytokine signals through the IL-17RA\/IL-17RC receptor complex","volume":"181","author":"Wright","year":"2008","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.1.36","article-title":"Cutting edge: interleukin 17 signals through a heteromeric receptor complex","volume":"177","author":"Toy","year":"2006","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903614","article-title":"IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis","volume":"184","author":"Hu","year":"2010","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071978","article-title":"Regulation of inflammatory responses by IL-17F","volume":"205","author":"Yang","year":"2008","journal-title":"J Exp Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2018.1463214","article-title":"Murine models of psoriasis and their usefulness for drug discovery","volume":"13","author":"Chuang","year":"2018","journal-title":"Expert Opin Drug Discov"},{"key":"B45","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","article-title":"beta-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis","volume":"139","author":"Kolbinger","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201948138","article-title":"Presence, function, and regulation of IL-17F-expressing human CD4(+) T cells","volume":"50","author":"Burns","year":"2020","journal-title":"Eur J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(03)00067-7","article-title":"The STIR-domain superfamily in signal transduction, development and immunity","volume":"28","author":"Novatchkova","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-020-01381-7","article-title":"Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis","volume":"69","author":"Rumberger","year":"2020","journal-title":"Inflamm Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190571","article-title":"Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis","volume":"47","author":"Chen","year":"2020","journal-title":"J Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13075-015-0688-0","article-title":"Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis","volume":"17","author":"Ca\u00f1ete","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B52","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.immuni.2020.02.004","article-title":"Structural analysis reveals that the cytokine IL-17F forms a homodimeric complex with receptor IL-17RC to drive IL-17RA-independent signaling","volume":"52","author":"Goepfert","year":"2020","journal-title":"Immunity"},{"key":"B53","doi-asserted-by":"publisher","first-page":"ra8","DOI":"10.1126\/scisignal.2000066","article-title":"IL-17 receptor signaling inhibits C\/EBPbeta by sequential phosphorylation of the regulatory 2 domain","volume":"2","author":"Shen","year":"2009","journal-title":"Sci Signal"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.07.063","article-title":"The IL-17F\/IL-17RC Axis Promotes Respiratory Allergy in the Proximal Airways","volume":"20","author":"De Luca","year":"2017","journal-title":"Cell Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01293","article-title":"TRAF Regulation of IL-17 Cytokine Signaling","volume":"10","author":"Swaidani","year":"2019","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102760","article-title":"Exploring IL-17 in spondyloarthritis for development of novel treatments and biomarkers","volume":"20","author":"Groen","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201212-2318OC","article-title":"Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma","volume":"188","author":"Busse","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.8.5462","article-title":"Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F","volume":"179","author":"Kuestner","year":"2007","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14387","article-title":"Early relapse of psoriasis after stopping brodalumab: a retrospective cohort study in 77 patients","volume":"31","author":"Masson Regnault","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3742","article-title":"Interleukin 17 is a chief orchestrator of immunity","volume":"18","author":"Veldhoen","year":"2017","journal-title":"Nat Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.immuni.2020.06.022","article-title":"The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24","volume":"53","author":"Chong","year":"2020","journal-title":"Immunity"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.09.040","article-title":"Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials","volume":"120","author":"Dick","year":"2013","journal-title":"Ophthalmology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.553742","article-title":"Innate Cells: The Alternative Source of IL-17 in Axial and Peripheral Spondyloarthritis","volume":"11","author":"Rosine","year":"2020","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/art.42090","article-title":"Characterization of Blood Mucosal Associated Invariant T (MAIT) cells in Axial Spondyloarthritis and of resident MAITs from control axial enthesis","volume":"74","author":"Rosine","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/ar4317","article-title":"Th17 and Th22 cells in psoriatic arthritis and psoriasis","volume":"15","author":"Benham","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet."},{"key":"B67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jid.2012.194","article-title":"The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings","volume":"133","author":"Martin","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00837-0","article-title":"Novel immune cell phenotypes in spondyloarthritis pathogenesis","volume":"43","author":"Mauro","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.clim.2014.01.009","article-title":"Secretion of interleukin-17 by CD8+ T cells expressing CD146 (MCAM)","volume":"152","author":"Dagur","year":"2014","journal-title":"Clin Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11926-021-00995-y","article-title":"Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis","volume":"23","author":"Nakamura","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1204327109","article-title":"Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing gammadelta cells","volume":"109","author":"Michel","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/art.41652","article-title":"Tissue-Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis","volume":"73","author":"Leijten","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.1038\/ncomms7046","article-title":"Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis","volume":"6","author":"Bowes","year":"2015","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/art.33415","article-title":"HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype","volume":"64","author":"Winchester","year":"2012","journal-title":"Arthritis Rheumatol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"7146","DOI":"10.1038\/ncomms8146","article-title":"Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1","volume":"6","author":"Cortes","year":"2015","journal-title":"Nat Commun"},{"key":"B77","doi-asserted-by":"publisher","first-page":"10870","DOI":"10.1038\/s41598-019-47310-5","article-title":"Increased frequency of activated CD8(+) T cell effectors in patients with psoriatic arthritis","volume":"9","author":"Diani","year":"2019","journal-title":"Sci Rep"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/art.41156","article-title":"Polyfunctional, Proinflammatory, Tissue-Resident Memory Phenotype and Function of Synovial Interleukin-17A+CD8+ T Cells in Psoriatic Arthritis","volume":"72","author":"Steel","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/exd.12487","article-title":"Cellular sources of IL-17 in psoriasis: a paradigm shift","volume":"23","author":"Keijsers","year":"2014","journal-title":"Exp Dermatol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1686156","article-title":"Preliminary Report on Interleukin-22, GM-CSF, and IL-17F in the Pathogenesis of Acute Anterior Uveitis","volume":"29","author":"Huang","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1038\/s41467-022-31229-z","article-title":"High-dimensional profiling reveals Tc17 cell enrichment in active Crohn's disease and identifies a potentially targetable signature","volume":"13","author":"Globig","year":"2022","journal-title":"Nat Commun"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2016.05.001","article-title":"IL-17+ CD8+ T cells: Differentiation, phenotype and role in inflammatory disease","volume":"178","author":"Srenathan","year":"2016","journal-title":"Immunol Lett"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12853","article-title":"Interleukin (IL)-9\/IL-9R axis drives gammadelta T cells activation in psoriatic arthritis patients","volume":"186","author":"Guggino","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939922","article-title":"CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells","volume":"39","author":"Haas","year":"2009","journal-title":"Eur J Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.06.020","article-title":"Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals","volume":"31","author":"Martin","year":"2009","journal-title":"Immunity"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8702-3","article-title":"The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.09.003","article-title":"Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07911-6","article-title":"RORgammat inhibition selectively targets IL-17 producing iNKT and gammadelta-T cells enriched in Spondyloarthritis patients","volume":"10","author":"Venken","year":"2019","journal-title":"Nat Commun"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e13572","DOI":"10.1111\/eci.13572","article-title":"Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: An update","volume":"51","author":"Hysa","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154855","article-title":"Functional significance of MAIT cells in psoriatic arthritis","volume":"125","author":"Raychaudhuri","year":"2020","journal-title":"Cytokine."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208902","article-title":"IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis","volume":"75","author":"Gracey","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.261","article-title":"The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells","volume":"134","author":"Teunissen","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-021-00391-w","article-title":"MAIT cells, guardians of skin and mucosa","volume":"14","author":"Nel","year":"2021","journal-title":"Mucosal Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-303339","article-title":"Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells","volume":"117","author":"Dusseaux","year":"2011","journal-title":"Blood"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048645","article-title":"Interleukin-17 producing mucosal associated invariant T cells - emerging players in chronic inflammatory diseases","volume":"50","author":"Pisarska","year":"2020","journal-title":"Eur J Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01610","article-title":"Increased IL-22- and IL-17A-Producing Mucosal-Associated Invariant T Cells in the Peripheral Blood of Patients With Ankylosing Spondylitis","volume":"9","author":"Toussirot","year":"2018","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13242","article-title":"MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis","volume":"31","author":"Haga","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/art.38376","article-title":"Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression","volume":"66","author":"Menon","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1038\/s41467-018-05095-7","article-title":"Altered thymic differentiation and modulation of arthritis by invariant NKT cells expressing mutant ZAP70","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat Commun"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9261-7","article-title":"Deficiency of invariant NK T cells in Crohn's disease and ulcerative colitis","volume":"52","author":"Grose","year":"2007","journal-title":"Dig Dis Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.7.4791","article-title":"Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses","volume":"181","author":"Grajewski","year":"2008","journal-title":"J Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.799560","article-title":"Dysregulated Peripheral Invariant Natural Killer T Cells in Plaque Psoriasis Patients","volume":"9","author":"Hu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02536.x","article-title":"The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behcet's uveitis","volume":"137","author":"Yu","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12658","article-title":"Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin","volume":"170","author":"Dyring-Andersen","year":"2014","journal-title":"Br J Dermatol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1002\/art.39261","article-title":"Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid","volume":"67","author":"Leijten","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700596","article-title":"Cutting Edge: Homeostasis of Innate Lymphoid Cells Is Imbalanced in Psoriatic Arthritis","volume":"200","author":"Soare","year":"2018","journal-title":"J Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.477","article-title":"Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis","volume":"134","author":"Villanova","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206323","article-title":"Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis","volume":"74","author":"Ciccia","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/art.40150","article-title":"Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis","volume":"69","author":"Cuthbert","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.03.016","article-title":"IL-17 and IFN-gamma producing NK and gammadelta-T cells are preferentially expanded in synovial fluid of patients with reactive arthritis and undifferentiated spondyloarthritis","volume":"183","author":"Chowdhury","year":"2017","journal-title":"Clin Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"12895","DOI":"10.1038\/s41598-017-13412-1","article-title":"NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.622306","article-title":"The Role of Natural Killer Cells in Autoimmune Diseases","volume":"12","author":"Kucuksezer","year":"2021","journal-title":"Front Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/248317","article-title":"NK cells and psoriasis","volume":"2011","author":"Dunphy","year":"2011","journal-title":"J BioMed Biotechnol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell."},{"key":"B115","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/925135","article-title":"CD4(+)T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.04.027","article-title":"Single-cell analysis implicates TH17-to-TH2 cell plasticity in the pathogenesis of palmoplantar pustulosis","volume":"150","author":"McCluskey","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/nature07021","article-title":"IL-21 and TGF-beta are required for differentiation of human T(H)17 cells","volume":"454","author":"Yang","year":"2008","journal-title":"Nature."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/ni1539","article-title":"TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838748","article-title":"TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells","volume":"39","author":"Santarlasci","year":"2009","journal-title":"Eur J Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-272153","article-title":"Low-strength T-cell activation promotes Th17 responses","volume":"116","author":"Purvis","year":"2010","journal-title":"Blood."},{"key":"B125","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1016\/j.celrep.2019.08.050","article-title":"TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions","volume":"28","author":"Leng","year":"2019","journal-title":"Cell Rep"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0221-5","article-title":"Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE","volume":"16","author":"Van Kaer","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jaut.2017.12.006","article-title":"Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis","volume":"87","author":"van Hamburg","year":"2018","journal-title":"J Autoimmun"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat Immunol"},{"key":"B129","article-title":"P34. Co-expression of IL17F and IL17A secretion by entheseal resident T-cells and circulating T-cells in preferentially from the CD4 T-cell subset","volume":"2022","author":"McDermott","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells\u2013a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00761","article-title":"Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications","volume":"8","author":"Lawand","year":"2017","journal-title":"Front Immunol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity."},{"key":"B133","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11926-015-0507-2","article-title":"IL-23 responsive innate-like T cells in spondyloarthritis: the less frequent they are, the more vital they appear","volume":"17","author":"Venken","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2013.122","article-title":"IL-17-producing NKT cells depend exclusively on IL-7 for homeostasis and survival","volume":"7","author":"Webster","year":"2014","journal-title":"Mucosal Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3726","article-title":"IL-17(+) gammadelta T cells as kick-starters of inflammation","volume":"18","author":"Papotto","year":"2017","journal-title":"Nat Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2014.03.034","article-title":"Development and regulation of RORgammat(+) innate lymphoid cells","volume":"588","author":"Cording","year":"2014","journal-title":"FEBS Lett"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1050382","article-title":"Innate lymphoid cells are pivotal actors in allergic, inflammatory and autoimmune diseases","volume":"11","author":"Sanati","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0191-y","article-title":"Mucosal-associated invariant T cells and disease","volume":"19","author":"Toubal","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1657","article-title":"The unique role of natural killer T cells in the response to microorganisms","volume":"5","author":"Tupin","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s13238-011-1006-5","article-title":"Structure and function of interleukin-17 family cytokines","volume":"2","author":"Zhang","year":"2011","journal-title":"Protein Cell"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0212-y","article-title":"Interleukin-7 protects against bacterial respiratory infection by promoting IL-17A-producing innate T-cell response","volume":"13","author":"Hassane","year":"2020","journal-title":"Mucosal Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/ijms17010046","article-title":"Sulfasalazine Treatment Suppresses the Formation of HLA-B27 Heavy Chain Homodimer in Patients with Ankylosing Spondylitis","volume":"17","author":"Yu","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J Exp Med"},{"key":"B146","article-title":"Presentation 3776. Translational data suggesting a pivotal role for IL-17A and IL-17F in hidradenitis suppurativa","author":"Maroof","year":"2022","journal-title":"SHSA 2022"},{"key":"B147","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/ijms19020440","article-title":"The Janus Face of NKT Cell Function in Autoimmunity and Infectious Diseases","volume":"19","author":"Torina","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/nri3174","article-title":"Targeting natural killer cells and natural killer T cells in cancer","volume":"12","author":"Vivier","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-69511-0_11","article-title":"iNKT cells in allergic disease","volume":"314","author":"Meyer","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity."},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003597","article-title":"Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity","volume":"186","author":"Lalor","year":"2011","journal-title":"J Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0444-8","article-title":"The biology and functional importance of MAIT cells","volume":"20","author":"Godfrey","year":"2019","journal-title":"Nat Immunol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.2220\/biomedres.38.111","article-title":"Possible involvement of mucosal-associated invariant T cells in the progression of inflammatory bowel diseases","volume":"38","author":"Tominaga","year":"2017","journal-title":"BioMed Res"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imm.12582","article-title":"Mucosal-associated invariant T cells in autoimmunity, immune-mediated diseases and airways disease","volume":"148","author":"Hinks","year":"2016","journal-title":"Immunology."},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/nri1309","article-title":"NKT cells: what's in a name","volume":"4","author":"Godfrey","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01450","article-title":"How Lipid-Specific T Cells Become Effectors: The Differentiation of iNKT Subsets","volume":"9","author":"Wang","year":"2018","journal-title":"Front Immunol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545532","article-title":"Syndecan-1 identifies and controls the frequency of IL-17-producing naive natural killer T (NKT17) cells in mice","volume":"45","author":"Dai","year":"2015","journal-title":"Eur J Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.06.025","article-title":"Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity."},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801631105","article-title":"Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population","volume":"105","author":"Coquet","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B160","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1084\/jem.20061551","article-title":"Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia","volume":"204","author":"Michel","year":"2007","journal-title":"J Exp Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.8.5167","article-title":"Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion","volume":"180","author":"Rachitskaya","year":"2008","journal-title":"J Immunol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901059","article-title":"Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions","volume":"183","author":"Doisne","year":"2009","journal-title":"J Immunol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.613204","article-title":"CD8(+)CD161(+) T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential","volume":"11","author":"Konduri","year":"2020","journal-title":"Front Immunol"}],"updated-by":[{"DOI":"10.3389\/fimmu.2023.1332177","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1191782\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T09:16:17Z","timestamp":1700644577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1191782\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":163,"alternative-id":["10.3389\/fimmu.2023.1191782"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1191782","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"article-number":"1191782"}}